盛帮股份 reported revenue of ¥0.22B for the period ended 2026-06-30, +0.1% year on year. Net income was ¥0.03B, a 16.0% net margin on a 33.7% gross margin. The largest revenue line is 汽车类 at 48% of the total. Free cash flow for the period was ¥0.01B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.22B | +0.1% |
| Gross profit | ¥0.07B | — |
| Operating income | ¥0.04B | — |
| Net income | ¥0.03B | -20.3% |
| Gross margin | 33.7% | Net margin 16.0% |
| Revenue Q/Q | +22.6% | — |
| Segment | Revenue | Share |
|---|---|---|
| 汽车类 | ¥0.10B | 47.9% |
| 电气类 | ¥0.10B | 43.9% |
| 航空类 | ¥0.01B | 5.7% |
| 其他(补充) | ¥0.00B | 1.4% |
| 其他产品 | ¥0.00B | 1.1% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.14B | 66.3% |
| R&D | ¥0.02B | 7.0% |
| SG&A | ¥0.02B | 7.4% |
| Tax & other | ¥0.00B | 2.2% |
| Item | Amount |
|---|---|
| Total assets | ¥1.09B |
| Total liabilities | ¥0.10B |
| Shareholders' equity | ¥0.99B |
| Equity / assets | 91.1% |
| Operating cash flow | ¥0.01B |
| Capital expenditure | ¥0.01B |
| Free cash flow | ¥0.01B |
| Cash conversion (OCF / net income) | 98% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
五洲医疗 ・ 华康洁净 ・ 和顺科技 ・ 瑞泰新材 ・ 普瑞眼科 ・ 宏源药业 ・ 杰创智能 ・ 威尔高 ・ 同星科技 ・ 通力科技 ・ 华融化学 ・ 普蕊斯
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies